Jul 6, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Advances in 3D Printing of Biopharmaceuticals Modern technology has enabled the development of novel dosage forms for targeted therapy. However, the fabrication of novel dosage forms at industrial scale is limited and the industry still runs on conventional drug...
Jun 19, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Improving patient adherence of oral drug products remains a key challenge for drug manufacturers alike. Check out this article and discussion between Pharmaceutical Technology and Adare Pharmaceuticals which discusses a unique approach for industry. 2024 Controlled...
Apr 14, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Physiologically based pharmacokinetic modeling is well established in the pharmaceutical industry and is accepted by regulatory agencies for the prediction of drug–drug interactions. However, physiologically based pharmacokinetic modeling is valuable to address a much...
Apr 13, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Oral Peptide Therapeutics – Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug developers can fully realize the vast potential. Numerous technologies are currently in...
Apr 12, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
There are various light-scattering tools available to the pharma/biotech industry. One such company ‘Wyatt Technology’, provides macromolecular and nanoparticle characterization solutions recognised by the FDA and several related technologies to their...
Recent Comments